Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.74B
-
Number of holders
-
2094
-
Total 13F shares, excl. options
-
1.28B
-
Shares change
-
+4.98M
-
Total reported value, excl. options
-
$101B
-
Value change
-
+$339M
-
Put/Call ratio
-
0.85
-
Number of buys
-
912
-
Number of sells
-
-1023
-
Price
-
$78.91
Significant Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q1 2020
2,301 filings reported holding ABT - ABBOTT LABORATORIES - Common Stock as of Q1 2020.
ABBOTT LABORATORIES - Common Stock (ABT) has 2,094 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.28B shares
of 1.74B outstanding shares and own 73.31% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (156M shares), BlackRock Inc. (128M shares), Capital Research Global Investors (95.9M shares), STATE STREET CORP (74.1M shares), Capital International Investors (55.8M shares), WELLINGTON MANAGEMENT GROUP LLP (43.2M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (27.4M shares), NORTHERN TRUST CORP (26.8M shares), BANK OF AMERICA CORP /DE/ (26.4M shares), and MORGAN STANLEY (25.4M shares).
This table shows the top 2094 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.